RHOU and Miyoshi myopathy: Remarkably, MM patients in high risk TC groups have significantly higher levels of RHOU mRNA that positively correlated with the presence of unfavorable cytogenetic alterations; however the sole presence of 1q gain, where RHOU gene is located, was not enough to cause a significant change in its expression.